50.5 F
New York
Friday, November 27, 2020

Novavax, Inc. (NASDAQ:NVAX) Rebounds Ahead of Phase 1/2 Trial Data

Must read

Can We Expect More Volatility From IT Tech Packaging Inc. (ITP)?

IT Tech Packaging Inc. (ITP) shares are trading at higher $0.73. To add more color to this target, the company’s high over the last...

Synlogic Inc. (NASDAQ:SYBX) is Waving the Bull Flag

Synlogic Inc. (SYBX) shares are trading at higher $2.45 and the avg recommendation for the stock is Strong Buy. To add more color to...

Switchback Energy Acquisition Corporation (NYSE:SBE) Recent Earnings Shows Major Concern

Switchback Energy Acquisition Corporation (SBE) shares are trading at lower $34.94. To add more color to this target, the company’s high over the last...

AnPac Bio-Medical Science Co. Ltd. (NASDAQ:ANPC) Stock is Soaring, Here is Why

AnPac Bio-Medical Science Co. Ltd. (ANPC) shares are trading at higher $7.14 and the avg recommendation for the stock is Moderate Buy. To add...

In recent times, Novavax, Inc. (NASDAQ:NVAX) has emerged as one of the better-performing stocks from the biotech sector. Earlier this year, the company announced significantly positive news with regards to NanoFlu, its flu vaccine product.

Investors are also awaiting data from the company’s Phase 1/2 trial, which is expected to be presented during the CDC ACIP meeting on October 30th

Coronavirus Play

However, it is as a ‘coronavirus play’ that the company has managed to really emerge as a winner as far as the stock price goes. Hence, it could be a good idea for investors to ponder if the Novavax stock can be a long term play or not.

In this regard, it is important to note that the company’s experimental COVID 19 vaccine NVX-CoV2373 is far from a sure thing yet. Many of the biggest pharmaceutical companies have paused their late-stage testing due to complications. Hence, it remains to be seen if Novavax’s vaccine manages to get emergency use authorization from the FDA.

On the other hand, NanoFlu is yet to get approval from the regulators. Hence, there is a significant degree of uncertainty with regard to Novavax’s two projects that have contributed to the rally this year.

Additionally, even if the two products are approved by the FDA, there is the possibility of similar vaccines from other companies proving to be more effective.

However, there is a certain degree of optimism about both products among experts. Additionally, if that happens, then the company could see revenue jump over the next five years. If it all pans out in that fashion, the Novavax could eventually be worth significantly more in half a decade and is worth keeping on the radar.

Latest article

Renewed Optimism is Surrounding Invitation Homes Inc. (NYSE:INVH)

Invitation Homes Inc. (INVH) shares are trading at higher $29.25 and the avg recommendation for the stock is Strong Buy, while the current analyst...

China Jo-Jo Drugstores Inc. (NASDAQ:CJJD) is Waving the Bull Flag

China Jo-Jo Drugstores Inc. (CJJD) shares are trading at higher $1.10. To add more color to this target, the company’s high over the last...

The Forecast Just Changed on Kensington Capital Acquisition Corp. (NYSE:KCAC)

Kensington Capital Acquisition Corp. (KCAC) shares are trading at higher $23.50. To add more color to this target, the company’s high over the last...

CommScope Holding Company Inc. (NASDAQ:COMM) on the Path to Profitability

CommScope Holding Company Inc. (COMM) shares are trading at higher $12.29 and the avg recommendation for the stock is Moderate Buy, while the current...

The Last Few Sessions Have NGL Energy Partners LP (NGL) Soaring

NGL Energy Partners LP (NGL) shares are trading at lower $2.41 and the avg recommendation for the stock is Hold, while the current analyst...